These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 17626709)
1. Predicting the risk of a false-positive test for women following a mammography screening programme. Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709 [TBL] [Abstract][Full Text] [Related]
2. Participation behaviour following a false positive test in the Copenhagen mammography screening programme. Andersen SB; Vejborg I; von Euler-Chelpin M Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321 [TBL] [Abstract][Full Text] [Related]
3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
4. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme. Castells X; Molins E; Macià F J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348 [TBL] [Abstract][Full Text] [Related]
5. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Hofvind S; Thoresen S; Tretli S Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474 [TBL] [Abstract][Full Text] [Related]
6. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. Hofvind S; Ponti A; Patnick J; Ascunce N; Njor S; Broeders M; Giordano L; Frigerio A; Törnberg S; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J; Lancucki L; Ducarroz S; Suonio E J Med Screen; 2012; 19 Suppl 1():57-66. PubMed ID: 22972811 [TBL] [Abstract][Full Text] [Related]
7. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis. Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112 [TBL] [Abstract][Full Text] [Related]
8. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark. Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242 [TBL] [Abstract][Full Text] [Related]
9. Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme. Molins E; Comas M; Román R; Rodríguez-Blanco T; Sala M; Macià F; Murta-Nascimento C; Castells X Public Health; 2009 Sep; 123(9):635-7. PubMed ID: 19733372 [No Abstract] [Full Text] [Related]
10. Performance of systematic and non-systematic ('opportunistic') screening mammography: a comparative study from Denmark. Bihrmann K; Jensen A; Olsen AH; Njor S; Schwartz W; Vejborg I; Lynge E J Med Screen; 2008; 15(1):23-6. PubMed ID: 18416951 [TBL] [Abstract][Full Text] [Related]
11. Seventeen-years overview of breast cancer inside and outside screening in Denmark. Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386 [TBL] [Abstract][Full Text] [Related]
12. The contribution of clinical breast examination to the accuracy of breast screening. Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967 [TBL] [Abstract][Full Text] [Related]
13. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer. Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH; J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638 [TBL] [Abstract][Full Text] [Related]
15. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693 [TBL] [Abstract][Full Text] [Related]
16. Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests. Baker SG; Kramer BS J Med Screen; 2008; 15(1):18-22. PubMed ID: 18416950 [TBL] [Abstract][Full Text] [Related]
17. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW Breast J; 2006; 12(4):338-42. PubMed ID: 16848843 [TBL] [Abstract][Full Text] [Related]
18. Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Brain K; Henderson BJ; Tyndel S; Bankhead C; Watson E; Clements A; Austoker J; Psychooncology; 2008 Dec; 17(12):1180-8. PubMed ID: 18506670 [TBL] [Abstract][Full Text] [Related]
19. Early outcome of mammography screening in Copenhagen 1991-99. Vejborg I; Olsen AH; Jensen MB; Rank F; Tange UB; Lynge E J Med Screen; 2002; 9(3):115-9. PubMed ID: 12370322 [TBL] [Abstract][Full Text] [Related]
20. Increased risk of breast cancer in women with false-positive test: the role of misclassification. von Euler-Chelpin M; Kuchiki M; Vejborg I Cancer Epidemiol; 2014 Oct; 38(5):619-22. PubMed ID: 25035157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]